The EVER genes - The genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients

Postepy Dermatologii i Alergologii

Volumn 33, Issue 2, 2016, Pages 75-80

  Kalinska Bienias, Agnieszka ^a   Kowalewski, Cezary ^a   Majewski, Sławomir ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Carcinogenesis; Epidermodysplasia verruciformis; Ever genes and proteins

Indexed keywords

CHROMOSOME PROTEIN; PROTEIN EVER1; PROTEIN EVER2; UNCLASSIFIED DRUG;

CANCER RISK; EPIDERMODYSPLASIA VERRUCIFORMIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE SYSTEM; KERATINOCYTE; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; PAPILLOMAVIRUS INFECTION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SKIN CARCINOGENESIS; ZINC HOMEOSTASIS;

EID: 84979263698     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/ada.2016.59145     Document Type: Review

References (46)

1. Lewandowsky F, Lutz W. Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch Dermatol Syphilol 1922;141:193-203.
2. Cockayne EA. Inherited abnormalities of the skin and its appendages. Oxford University Press, London 1933.
3. Lutzner MA. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer 1978;65:169-82.
4. Androphy EJ, Dvoretzky I, Lowy DR. X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol 1985;121:864-8.
5. Ramoz N, Rueda LA, Bouadjar B, et al. A susceptibility locus or epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999;112:259-63.
6. Ramoz N, Taieb A, Rueda LA, et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 2000;114:1148-53.
7. Orth G. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr Top Microbiol Immunol 2008;321:59-83.
8. Lazarczyk M, Pons C, Mendoza JA, et al. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 2008;205:35-42.
9. Nair RP, Henseler T, Jenisch S, et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997;6:1349-56.
10. Majewski S, Favre M, Orth G, Jablonska S. Is human papillomavirus type 5 the putative autoantigen involved in psoriasis? J Invest Dermatol 1998;111:541-2.
11. Deloukas P, Schuler GD, Gyapay G, et al. A physical map of 30, 000 human genes. Science 1998;282:744-6.
12. Plummer SJ, Simmons JA, Adams L, Casey G. Mapping of 228 ESTs and 26 genes into an integrated physical and genetic map of human chromosome 17. Genomics 1997;45:140-6.
13. Kuhlenbaumer G, Schirmacher A, Meuleman J, et al. A sequence-ready BAC/PAC contig and partial transcript map of approximately 1.5 Mb in human chromosome 17q25 comprising multiple disease genes. Genomics 1999;62:242-50.
14. Yasunaga S, Grati M, Cohen-Salmon M, et al. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 1999;21:363-9.
15. Ramoz N, Rueda LA, Bouadjar B, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002;32:579-81.
16. Keresztes G, Mutai H, Heller S. TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics 2003;4:24.
17. Kurima K, Yang Y, Sorber K, Griffith AJ. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 2003;82:300-8.
18. Kurima K, Peters LM, Yang Y, et al. Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet 2002;30:277-84.
19. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006;18:362-74.
20. Arnold AW, Burger B, Kump E, et al. Homozygosity for the c.917A→T (p. N3061) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz. Dermatology 2011;222:81-6.
21. Hohenstein E, Rady PL, Hergersberg M, et al. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A→T polymorphism in the TMC8/EVER2 gene. Dermatology 2009;218:114-8.
22. Zuo YG, Ma D, Zhang Y, et al. Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis. J Dermatol Sci 2006;44:153-9.
23. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004;101:6062-7.
24. Lazarczyk M, Dalard C, Hayder M, et al. EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation. PLoS One 2012;7:e39995.
25. Crequer A, Picard C, Pedergnana V, et al. EVER2 deficiency is associated with mild T-cell abnormalities. J Clin Immunol 2013;33:14-21.
26. Eide DJ. Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 2006;1763:711-22.
27. Sekler I, Sensi SL, Hershfinkel M, Silverman W F. Mechanism and regulation of cellular zinc transport. Mol Med 2007;13:337-43.
28. Yamasaki S, Sakata-Sogawa K, Hasegawa A, et al. Zinc is a novel intracellular second messenger. J Cell Biol 2007;177:637-45.
29. Lazarczyk M, Favre M. Role of Zn2+ ions in host-virus interactions. J Virol 2008;82:11486-94.
30. Lazarczyk M, Cassonnet P, Pons C, et al. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev 2009;73:348-70.
31. Gaud G, Guillemot D, Jacob Y, et al. EVER2 protein binds TRADD to promote TNF-alpha-induced apoptosis. Cell Death Dis 2013;4:e499.
32. Vuillier F, Gaud G, Guillemot D, et al. Loss of the HPV-infection resistance EVER2 protein impairs NF-kappaB signaling pathways in keratinocytes. PLoS One 2014;9:e89479.
33. Eom SJ, Kim EY, Lee JE, et al. Zn (2+) induces stimulation of the c-Jun. N-terminal kinase signaling pathway through phosphoinositide 3-Kinase. Mol Pharmacol 2001;59:981-6.
34. Nonnenmacher M, Salmon J, Jacob Y, et al. Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis. J Virol 2006;80:4890-900.
35. Genther Williams SM, Disbrow GL, et al. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res 2005;65:6534-42.
36. Patel AS, Karagas MR, Pawlita M, et al. Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int J Cancer 2008;122:2377-9.
37. Pfister H, Fuchs PG, Majewski S, et al. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 2003;295:273-9.
38. Kalinska-Bienias A, Kostrzewa G, Malejczyk M, et al. Possible association between actinic keratosis and polymorphism rs7208422 (c.917A→T, p. N3061) of EVER2 gene in non-EV patients. Clin Exp Dermatol 2015;40:318-23.
39. Wang SS, Gonzalez P, Yu K, et al. Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One 2010;5:e8667.
40. Castro FA, Ivansson EL, Schmitt M, et al. Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. Int J Cancer 2012;130:349-55.
41. Aochi S, Nakanishi G, Suzuki N, et al. A novel homozygous mutation of the EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. Br J Dermatol 2007;157:1265-6.
42. Tate G, Suzuki T, Kishimoto K, Mitsuya T. Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. J Hum Genet 2004;49:223-5.
43. Gober MD, Fishelevich R, Zhao Y, et al. Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. J Invest Dermatol 2008;128:1460-9.
44. Rady PL, De Oliveira WR, He Q, et al. Novel homozygous nonsense TMC8 mutation detected in patients with epidermodysplasia verruciformis from a Brazilian family. Br J Dermatol 2007;157:831-3.
45. Berthelot C, Dickerson MC, Rady P, et al. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J Am Acad Dermatol 2007;56:882-6.
46. Sun XK, Chen JF, Xu AE. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol 2005;30:573-4.